Stay updated on DAPA-MI Trial: Dapagliflozin Post Heart Attack

Sign up to get notified when there's something new on the DAPA-MI Trial: Dapagliflozin Post Heart Attack page.
Latest website image capture
Clouds background image

Latest updates to the DAPA-MI Trial: Dapagliflozin Post Heart Attack page

  1. Check
    3 days ago
    Change Detected
    Summary
    The site revision identifier in the footer changed from v3.7.2 to v3.8.0; the study record content remains unchanged.
    Difference
    0.1%
    Check dated 2026-11-01T01:20:11.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    A banner announces that NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” across its content, with updates and FAQs available.
    Difference
    0.4%
    Check dated 2026-10-25T01:24:13.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The site footer’s displayed revision changes from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T00:59:46.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays software revision v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-11T01:45:00.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The revision label on the history page was updated from v3.6.6 to v3.7.0, signaling a new version of the study record.
    Difference
    0.1%
    Check dated 2026-09-20T00:33:03.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    The revision tag in the history view was updated from v3.6.5 to v3.6.6, indicating a newer version of the record. This is an administrative update to the document version rather than a change to the study data or content.
    Difference
    0.1%
    Check dated 2026-08-29T19:56:08.000Z thumbnail image

Stay in the know with updates to DAPA-MI Trial: Dapagliflozin Post Heart Attack

Enter your email address, and we'll notify you when there's something new on the DAPA-MI Trial: Dapagliflozin Post Heart Attack page.